Retinal Artery Occlusion: Clinical Trials

2 trials for Retinal Artery Occlusion, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 unknown. 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 22Completed 1, Unknown 1

Follow Retinal Artery Occlusion: new trials by email Literature Review of Retinal Artery Occlusion trials Research Report on Retinal Artery Occlusion

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of the Efficacy and Safety of KUS121 in Participants With Acute Non-Arteritic Central Retinal Artery Occlusion (CRAO)
KUS121 high dose, KUS121 low dose, Sham procedure - Central Retinal Artery Occlusion
Phase 2CompletedKyoto Drug Discovery and Development Co., Ltd.172024-04-162026-02-18
The Effect of A2A Adrenoceptor Stimulation on the Diameter of Retinal Arterioles During Hypoxia in Vivo
Hypoxia, Regadenoson - Retinal Artery Occlusion
Phase 2UnknownUniversity of Aarhus202017-03-222017-03-28

Narrower conditions

Hypoxia (1)

Broader conditions

Arterial Occlusive Diseases (2)  ·  Cardiovascular Diseases (2)  ·  Eye Diseases (2)  ·  Retinal Diseases (2)  ·  Vascular Diseases (2)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Signs and Symptoms (1)  ·  Signs and Symptoms, Respiratory (1)

Interventions

KUS121 (1)  ·  regadenoson (1)

Sponsors

Kyoto Drug Discovery and Development Co., Ltd. (1)  ·  University of Aarhus (1)

Countries

Denmark (1)  ·  United States (1)

Top investigators

Kunihiro Musashi, MD., Ph.D. (1)  ·  Toke Bek, Chair (1)